Science1 day ago
ALX Oncology Reports Q4 Earnings with Promising Clinical Updates
ALX Oncology (NASDAQ:ALXO) has provided a comprehensive update during its fourth-quarter earnings call, highlighting significant progress in its clinical programs, particularly with the CD47 blocker evorpacept...
